We always strive to do more in order to positively impact our patients consumers, employees, communities as well as our shareholders. We firmly believed that doing business with a conscience is integral in order to sustain our business success.
29 NOVEMBER 2023
Pharmaniaga Berhad’s (Pharmaniaga) announces its plan to raise up to RM655 million to
bolster its financial position and revitalise financial health, marking a crucial step toward
exiting its Practice Note 17 (PN17) status.
11 AUGUST 2023
Pharmaniaga Berhad (Pharmaniaga) is embarking on an extensive business restructuring exercise
that includes implementing rigorous fiscal discipline initiatives across its operations as part of the
Group’s comprehensive recovery plan.
26 JULY 2023
Pharmaniaga Berhad (Pharmaniaga) and CSPC Pharmaceutical Group Limited (CSPC) of China
today forged a partnership on the research and development, manufacturing, and commercialisation
of innovative pharmaceutical and biopharmaceutical products.
21 JULY 2023
Pharmaniaga Berhad (Pharmaniaga) today has successfully completed its 10% first private share
placement exercise and a second tranche of 10% is expected to be taken up by Armed Forces Fund
Board (LTAT), subject to shareholders’ approval.
12 JUNE 2023
Pharmaniaga Berhad (Pharmaniaga) outlines a strategic plan to address the challenges presented by its Practice Note 17 (PN17) status, with a strong focus on financial recalibration and a resolute commitment
to overcome obstacles. The Group charts a path towards a resilient recovery and rapid …